These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 20092724)
1. [A prospective study of FOLFOX7 scheme as neoadjuvant chemotherapy for stage III gastric adenocarcinoma]. Liu YH Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(17):1305-8. PubMed ID: 20092724 [TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma. Alexander HR; Grem JL; Hamilton JM; Pass HI; Hong M; Fraker DL; Steinberg SM; McAtee N; Allegra BC; Johnston PG Cancer J Sci Am; 1995; 1(1):49-54. PubMed ID: 9166454 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer. Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A Oncology; 2004; 67(1):48-53. PubMed ID: 15459495 [TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma]. Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853 [TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemotherapy for locally advanced gastric cancer]. Kalmár K; Cseke L; Káposztás Z; Horváth G; Varga E Magy Seb; 2003 Oct; 56(5):177-84. PubMed ID: 15022621 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of neoadjuvant chemotherapy with modified FOLFOX7 regimen on the treatment of advanced gastric cancer. Zhang J; Chen RX; Zhang J; Cai J; Meng H; Wu GC; Zhang ZT; Wang Y; Wang KL Chin Med J (Engl); 2012 Jun; 125(12):2144-50. PubMed ID: 22884144 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer. Li ZY; Koh CE; Bu ZD; Wu AW; Zhang LH; Wu XJ; Wu Q; Zong XL; Ren H; Tang L; Zhang XP; Li JY; Hu Y; Shen L; Ji JF J Surg Oncol; 2012 Jun; 105(8):793-9. PubMed ID: 22189752 [TBL] [Abstract][Full Text] [Related]
8. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048 [TBL] [Abstract][Full Text] [Related]
9. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917 [TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response]. Káposztás Z; Cseke L; Kalmár K; Horváth OP Magy Seb; 2002 Oct; 55(5):321-4. PubMed ID: 12474518 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma. Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer. Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246 [TBL] [Abstract][Full Text] [Related]
13. The combination of docetaxel and cisplatin plus fluorouracil as neoadjuvant chemotherapy in the treatment of T4 stage gastric cancer. Guo MG; Zheng Q; Cheng Z; Wang Y; Feng CN; Yang Z Surg Oncol; 2010 Mar; 19(1):1-3. PubMed ID: 19006661 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy with cisplatin, etoposide, fluorouracil and leucovorin for gastric carcinoma. Papadakou M; Xydakis E; Bonios M; Makropoulou E; Boukis C; Kakavoulis T; Karaliotas C; Panagos G J BUON; 2006; 11(3):285-9. PubMed ID: 17309151 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529 [TBL] [Abstract][Full Text] [Related]
16. A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer. Chen JS; Rau KM; Chen YY; Huang JS; Yang TS; Lin YC; Liau CT; Lee KD; Su YC; Kao RH Cancer Chemother Pharmacol; 2009 Apr; 63(5):819-25. PubMed ID: 18663448 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma. Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959 [TBL] [Abstract][Full Text] [Related]
18. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer. Amini A; Sanati H Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120 [TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: a retrospective comparative study. Wang LB; Shen JG; Xu CY; Chen WJ; Song XY; Yuan XM Hepatogastroenterology; 2008; 55(86-87):1895-8. PubMed ID: 19102417 [TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma. Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]